bioMérieux ConnectionAn educational resource brought to you by bioMérieux, Inc.
An educational resource brought to you by bioMérieux, Inc.
As infectious diseases evolve, the medical community has been working to meet the challenge by updating and improving the tools we use to combat infections. Right now, biopharmaceutical research companies have 421 medicines and vaccines in development to treat or prevent fungal, bacterial, and viral infections.
Three well-established infectious diseases—Tuberculosis, malaria, and HIV—are poised to kill millions worldwide, with decades of healthcare progress that could be lost due to disruptions caused by COVID-19. Even under normal circumstances, the toll these three diseases exact worldwide is staggering.
The World Health Organization (WHO) estimates that Tuberculosis (TB) caused 1.5 million deaths in 2018. It’s one of the top ten causes of death worldwide and the leading cause of death from a single infectious agent.
Each year, healthcare organizations, schools, governments, companies, and communities around...
Each year, more than 700,000 people lose their lives to...